SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOVOLENTA, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.794
EU - Europa 4.320
AS - Asia 3.254
SA - Sud America 524
AF - Africa 87
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.630
FI - Finlandia 1.972
SG - Singapore 1.293
CN - Cina 753
PL - Polonia 596
IT - Italia 468
BR - Brasile 426
DE - Germania 374
VN - Vietnam 367
HK - Hong Kong 238
GB - Regno Unito 203
UA - Ucraina 190
TR - Turchia 159
SE - Svezia 122
FR - Francia 106
JP - Giappone 88
CA - Canada 87
IN - India 83
RU - Federazione Russa 82
BD - Bangladesh 65
ID - Indonesia 59
MX - Messico 55
AR - Argentina 45
BE - Belgio 43
ZA - Sudafrica 37
NL - Olanda 36
ES - Italia 32
IQ - Iraq 28
PK - Pakistan 19
CO - Colombia 18
IE - Irlanda 16
UZ - Uzbekistan 15
AT - Austria 13
KE - Kenya 13
LT - Lituania 13
SA - Arabia Saudita 12
MA - Marocco 11
MY - Malesia 11
PH - Filippine 10
CZ - Repubblica Ceca 9
EG - Egitto 8
EC - Ecuador 7
RO - Romania 7
AU - Australia 6
CH - Svizzera 6
CL - Cile 6
HR - Croazia 6
JM - Giamaica 6
TN - Tunisia 6
VE - Venezuela 6
EU - Europa 5
PY - Paraguay 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
KG - Kirghizistan 4
LB - Libano 4
OM - Oman 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KR - Corea 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
GE - Georgia 2
IR - Iran 2
KH - Cambogia 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GL - Groenlandia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
Totale 14.982
Salva come PNG Salva come JPEG
Città #
Helsinki 1.888
Ashburn 783
Singapore 782
Warsaw 591
Woodbridge 555
Fairfield 515
San Jose 460
Ann Arbor 386
Houston 334
Chandler 322
Santa Clara 253
Beijing 247
Hong Kong 234
Jacksonville 220
Seattle 219
Wilmington 201
Cambridge 174
Dallas 138
New York 138
Ferrara 131
Los Angeles 127
Ho Chi Minh City 126
Munich 124
Izmir 96
Council Bluffs 87
Hanoi 84
Nanjing 83
Tokyo 83
Milan 75
Princeton 60
Lauterbourg 52
Shanghai 52
Boardman 49
San Diego 49
London 46
Jakarta 45
São Paulo 43
Turku 39
Brussels 38
Bremen 37
Mexico City 37
Buffalo 33
Dearborn 30
Orem 30
Toronto 29
Chicago 28
Frankfurt am Main 27
Johannesburg 27
Bologna 24
The Dalles 24
Chennai 23
Falls Church 23
Nanchang 23
Tianjin 23
Brooklyn 22
Montreal 21
Shenyang 20
Denver 18
Nuremberg 18
Phoenix 18
Poplar 18
Stockholm 18
Atlanta 17
Hefei 17
Kunming 16
Moscow 16
Rio de Janeiro 16
Changsha 14
Des Moines 14
Boston 13
Brasília 13
Da Nang 13
Hebei 13
Nairobi 13
Rome 13
Tashkent 13
Belo Horizonte 12
Dong Ket 12
Haiphong 12
Redwood City 12
Curitiba 11
Jinan 11
Ottawa 11
Washington 11
Auburn Hills 10
Baghdad 10
Columbus 10
Falkenstein 10
Hangzhou 10
San Mateo 10
Ankara 9
Bari 9
Charlotte 9
Dublin 9
New Delhi 9
Brno 8
Mountain View 8
Paris 8
Querétaro 8
San Francisco 8
Totale 10.938
Salva come PNG Salva come JPEG
Nome #
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.053
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 472
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 426
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 411
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 348
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 299
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 287
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 282
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 281
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 279
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 279
Crispr/Cas9-based COL7A1 editing for recessive dystrophic epidermolysis bullosa 276
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 272
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 272
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 269
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 267
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 264
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 260
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 251
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 246
Autosomal recessive Bethlem myopathy 244
Exon skipping-mediated dystrophin reading frame restoration for small mutations 241
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 231
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 224
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 215
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 209
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 208
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 207
Transcriptional behavior of DMD gene duplications in DMD/BMD males 207
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 204
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 202
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 196
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 194
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 183
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 175
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 170
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 169
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 161
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 161
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 161
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 159
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 156
null 155
Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 147
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 147
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 146
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to titin 146
Autosomal recessive Bethlem myopathy 145
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 143
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 142
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 140
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 138
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 136
Studio di CNVs nel locus HLA (6p21.32) mediante Array CGH in pazienti con Sclerosi Multipla e malformazioni venose 135
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach 135
null 131
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 129
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 126
Transcriptional enhancement as therapeutic approach of coagulation factor VII promoter mutations 121
A new rat model for Duchenne muscular dystrophy generated by CRISPR-induced deletion of Exon 45 114
null 113
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 109
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 106
Efficient generation of mouse models with the CRISPR/Cas9 technology 99
null 86
Targeted Genome Editing in Spinal Muscular Atrophy 76
A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions 16
Totale 15.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/2022746 41 55 47 37 33 35 67 38 31 62 86 214
2022/2023812 75 82 8 111 154 93 52 63 85 11 44 34
2023/2024435 35 47 37 10 35 97 10 30 10 5 12 107
2024/20251.968 41 30 158 119 254 149 88 98 400 158 274 199
2025/20266.712 514 156 409 581 768 325 652 281 2.293 498 197 38
Totale 15.152